What is Haddon Renal?
Established in 1971, Haddon Renal Medical Specialists has maintained a dominant market position as a premier provider of comprehensive nephrology care. The organization specializes in the management of chronic kidney disease, hypertension, transplant support, and intricate electrolyte disorders. By integrating decades of clinical expertise with modern medical protocols, Haddon Renal serves as a critical pillar in the regional healthcare ecosystem, ensuring high-acuity patient outcomes through a multidisciplinary approach to renal health.
How much funding has Haddon Renal raised?
Haddon Renal has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Haddon Renal
PPP
Public-Private Partnership
What's next for Haddon Renal?
The infusion of capital is expected to catalyze the next phase of operational scaling and technological integration for Haddon Renal. As the organization navigates the complexities of late-stage growth, the focus will likely shift toward expanding its footprint in transplant services and enhancing its digital health capabilities for remote patient monitoring. By leveraging this strategic financing, Haddon Renal is well-positioned to optimize its service delivery models, ensuring that its long-term commitment to patient care remains resilient against evolving healthcare market demands and regulatory shifts.
See full Haddon Renal company page
